ROC curve revealed that tissue CXCL13 and serum CXCL13 expression might be a potential diagnostic biomarker for ccRCC with an AUC of 0.809 and 0.704, respectively (Figure 3B). Here, CXCL13 is linked to nonpapillary renal cell carcinoma.